A detailed history of Parsec Financial Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 187,426 shares of BMY stock, worth $10.6 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
187,426
Previous 209,943 10.73%
Holding current value
$10.6 Million
Previous $15.1 Million 13.99%
% of portfolio
0.55%
Previous 0.67%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

SELL
$65.71 - $74.53 $1.48 Million - $1.68 Million
-22,517 Reduced 10.73%
187,426 $13 Million
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $280,220 - $331,820
4,092 Added 1.99%
209,943 $15.1 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $3,681 - $2.18 Million
28,322 Added 15.95%
205,851 $14.6 Million
Q2 2022

Jul 06, 2022

BUY
$72.62 - $79.98 $986,833 - $1.09 Million
13,589 Added 8.29%
177,529 $13.7 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $2.61 Million - $3.13 Million
42,446 Added 34.94%
163,940 $12 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $343,071 - $399,940
6,397 Added 5.56%
121,494 $7.58 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $2.5 Million - $2.93 Million
42,276 Added 58.05%
115,097 $6.84 Million
Q2 2021

Jul 26, 2021

BUY
$61.91 - $67.42 $1.55 Million - $1.68 Million
24,989 Added 52.24%
72,821 $4.87 Million
Q1 2021

Apr 23, 2021

BUY
$59.34 - $66.74 $2.4 Million - $2.7 Million
40,444 Added 547.43%
47,832 $3.02 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $142,502 - $161,481
2,468 Added 50.16%
7,388 $458,000
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $52,318 - $57,976
911 Added 22.72%
4,920 $297,000
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $1,096 - $1,281
-20 Reduced 0.5%
4,009 $236,000
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $29,371 - $42,683
633 Added 18.64%
4,029 $225,000
Q4 2019

Jan 29, 2020

SELL
$49.21 - $64.19 $29,526 - $38,514
-600 Reduced 15.02%
3,396 $218,000
Q3 2019

Oct 23, 2019

BUY
$42.77 - $50.71 $170,908 - $202,637
3,996 New
3,996 $203,000
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $187,270 - $207,079
-4,197 Closed
0 $0
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $213,011 - $253,989
-4,721 Reduced 52.94%
4,197 $200,000
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $3,218 - $4,173
-66 Reduced 0.73%
8,918 $464,000
Q3 2018

Oct 30, 2018

BUY
$55.19 - $62.25 $24,338 - $27,452
441 Added 5.16%
8,984 $558,000
Q2 2018

Jul 26, 2018

BUY
$50.53 - $62.98 $59,019 - $73,560
1,168 Added 15.84%
8,543 $473,000
Q4 2017

Jan 26, 2018

BUY
$59.94 - $65.35 $19,540 - $21,304
326 Added 4.62%
7,375 $452,000
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $389,316 - $449,303
7,049
7,049 $449,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parsec Financial Management, Inc. Portfolio

Follow Parsec Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.